Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-000214

Chief Accounting Officer sold 50,000 shares at an average $26.10 ($1,305,098)

  • Chief Accounting Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lyon Joseph Douglas · Chief Accounting Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-30 Exercise or conversion : show line 1 in the form +4,167 $3.88 $16,168 4,167 D
2020-12-30 Exercise or conversion : show line 2 in the form +20,833 $8.27 $172,289 25,000 D
2020-12-30 Sale : show line 3 in the form −25,000 $26.07 $651,753 0 D
2021-01-04 Exercise or conversion : show line 4 in the form +25,000 $8.27 $206,750 25,000 D
2021-01-04 Sale : show line 5 in the form −25,000 $26.13 $653,345 0 D
Open-market sales · 50,000 sh · avg $26.10 · $1,305,098

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-12-30 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −4,167 0 D
2020-12-30 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −20,833 79,167 D
2021-01-04 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −25,000 54,167 D
Loading xslF345X03/doc4.xml…